Tennessee Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tennessee Business Gazette.

Press releases published on April 27, 2026

Apr. 27, 2026

Auddia Announces Closing of $12 Million Public Offering

Indeterminate GlobeNewswire

Apr. 27, 2026

BABCOCK & WILCOX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urges Babcock & Wilcox Enterprises, Inc. Investors with Large Losses to Contact the Firm

Indeterminate GlobeNewswire

Apr. 27, 2026

Tessera Therapeutics to Present New Preclinical Data Supporting In Vivo Program in Sickle Cell Disease and Advancements in In Vivo CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

AI Tools Give PR Teams Measurable Citation Data for First Time

Indeterminate GlobeNewswire

Apr. 27, 2026

Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

New Crypto Pepeto DeFi Exchange Hits Final Testing While Dogecoin Price Prediction Reaches $5 as Meme Rotation Picks Up

Indeterminate GlobeNewswire

Apr. 27, 2026

First Bank Announces First Quarter 2026 Net Income of $7.6 Million

Indeterminate GlobeNewswire

Apr. 27, 2026

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Apr. 27, 2026

Freddie Mac Issues Monthly Volume Summary for March 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Marex Group plc to announce first quarter 2026 results on May 6, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Asgard Therapeutics announces oral presentation at ASGCT 2026, showcasing advanced preclinical data on AT-108 – its first-in-class, off-the-shelf, gene-based cancer immunotherapy

Indeterminate GlobeNewswire

Apr. 27, 2026

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Gulf Resources, Inc. Receives NASDAQ Notice to Late Filing of Its Annual Report

Indeterminate GlobeNewswire

Apr. 27, 2026

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Cellectis présente sa plateforme d’édition épigénétique pour éteindre des gènes sans modifier l’ADN, lors du congrès annuel de l’ASGCT

Indeterminate GlobeNewswire

Apr. 27, 2026

Charlton Aria Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination

Indeterminate GlobeNewswire

Apr. 27, 2026

Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire